American Custom Chemicals Corporation (ACC Corporation) is a leading player in the life sciences sector, catering to the biotech, pharma, and chemicals industries. The company offers a wide range of services including custom synthesis, active pharmaceutical intermediates, reference standards, medicinal chemistry cores, and biologicals custom synthesis. ACC Corporation's extensive catalog boasts over 100,000 products available for immediate sale, coupled with comprehensive documentation. With a solid foundation laid in 1994, the headquarters of American Custom Chemicals Corporation are located in the United States. The diverse range of offerings by ACC Corporation reflects its commitment to serving the dynamic needs of the pharmaceutical and biotechnology sectors. The company's provision of custom synthesis spans from lab scale to kilo scale, which can encompass complex 6-8 step synthesis processes. Notably, the affordable price points at $6000-$8000/100mg & $8000-$10,000/gm for custom synthesis accompanied by a host of essential documentation make the services attractive. Moreover, the company's massive library of over 4000 active pharmaceutical intermediates and a catalog of over 100,000 products positions it as a prominent solution provider in the industry. The absence of specific information regarding the last investment and last investment investors warrants further investigation into the company's current financial standing and potential opportunities for investment. Nevertheless, American Custom Chemicals Corporation exudes potential for expansion and innovation within the biotechnology and pharmaceutical industries.
There is no investment information
No recent news or press coverage available for American Custom Chemicals Corporation.